Dedicare AB (publ) operates as a staffing company in the healthcare industry primarily in Sweden, Norway, Finland, and Denmark. More Details
Flawless balance sheet with proven track record.
Share Price & News
How has Dedicare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: DEDI is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: DEDI's weekly volatility (5%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: DEDI underperformed the Swedish Healthcare industry which returned 41.6% over the past year.
Return vs Market: DEDI underperformed the Swedish Market which returned 28.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Dedicare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StDedicare AB (publ)'s (STO:DEDI) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
1 month ago | Simply Wall StWe Think Dedicare's (STO:DEDI) Statutory Profit Might Understate Its Earnings Potential
1 month ago | Simply Wall StWould Shareholders Who Purchased Dedicare's (STO:DEDI) Stock Three Years Be Happy With The Share price Today?
Is Dedicare undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: DEDI (SEK50.5) is trading below our estimate of fair value (SEK63.02)
Significantly Below Fair Value: DEDI is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: DEDI is good value based on its PE Ratio (13.1x) compared to the SE Healthcare industry average (19.5x).
PE vs Market: DEDI is good value based on its PE Ratio (13.1x) compared to the Swedish market (23.9x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate DEDI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: DEDI is overvalued based on its PB Ratio (3.5x) compared to the SE Healthcare industry average (1.6x).
How is Dedicare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dedicare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Dedicare is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Dedicare competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Dedicare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: DEDI has high quality earnings.
Growing Profit Margin: DEDI's current net profit margins (4.1%) are higher than last year (3.4%).
Past Earnings Growth Analysis
Earnings Trend: DEDI's earnings have declined by 10.3% per year over the past 5 years.
Accelerating Growth: DEDI's earnings growth over the past year (36.6%) exceeds its 5-year average (-10.3% per year).
Earnings vs Industry: DEDI earnings growth over the past year (36.6%) underperformed the Healthcare industry 39.3%.
Return on Equity
High ROE: DEDI's Return on Equity (26.7%) is considered high.
How is Dedicare's financial position?
Financial Position Analysis
Short Term Liabilities: DEDI's short term assets (SEK283.6M) exceed its short term liabilities (SEK167.9M).
Long Term Liabilities: DEDI's short term assets (SEK283.6M) exceed its long term liabilities (SEK81.3M).
Debt to Equity History and Analysis
Debt Level: DEDI is debt free.
Reducing Debt: DEDI had no debt 5 years ago.
Debt Coverage: DEDI has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: DEDI has no debt, therefore coverage of interest payments is not a concern.
What is Dedicare current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: DEDI's dividend (4.95%) is higher than the bottom 25% of dividend payers in the Swedish market (1.23%).
High Dividend: DEDI's dividend (4.95%) is in the top 25% of dividend payers in the Swedish market (3.66%)
Stability and Growth of Payments
Stable Dividend: DEDI has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: DEDI's dividend payments have increased, but the company has only paid a dividend for 9 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (65.1%), DEDI's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Krister Widstrom (58 yo)
Mr. Krister Widstrom serves as a President and Chief Executive Officer at Dedicare AB (publ), which he joined in 2017.
|Independent Director||1.92yrs||no data||no data|
|Independent Director||10.08yrs||kr165.00k||0.019% |
|Independent Director||1.17yrs||no data||no data|
Experienced Board: DEDI's board of directors are considered experienced (7.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.8%.
Dedicare AB (publ)'s company bio, employee growth, exchange listings and data sources
- Name: Dedicare AB (publ)
- Ticker: DEDI
- Exchange: OM
- Founded: 1996
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: kr469.770m
- Shares outstanding: 9.40m
- Website: https://www.dedicare.se
Number of Employees
- Dedicare AB (publ)
- Ringvägen 100
- uppgång E, 10 tr
- Stockholm County
- 118 60
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|DEDI||OM (OMX Nordic Exchange Stockholm)||Yes||Class B Shares||SE||SEK||May 2011|
|0P3K||LSE (London Stock Exchange)||Yes||Class B Shares||GB||SEK||May 2011|
|DEDIS||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Class B Shares||GB||SEK||May 2011|
Dedicare AB (publ) operates as a staffing company in the healthcare industry primarily in Sweden, Norway, Finland, and Denmark. The company hires and recruits doctors, nurses, social workers, and managers,...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/03/03 20:02|
|End of Day Share Price||2021/03/03 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.